Ellen M. Mowry, MD, MCR
Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ellen M. Mowry, MD, MCR as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07497399 · Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple SclerosisJohns Hopkins University · recruiting · Multiple Sclerosis
- N/ANCT03500328 · Traditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialJohns Hopkins University · completed · Multiple Sclerosis, Relapsing-Remitting · principal investigator
- Ph1NCT02253264 · A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis PatientsJohns Hopkins University · completed · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
- N/ANCT01667796 · Pharmacokinetics of Vitamin D in Multiple Sclerosis and in HealthJohns Hopkins University · completed · Multiple Sclerosis, Relapsing-remitting
- Ph3NCT01490502 · Vitamin D Supplementation in Multiple SclerosisJohns Hopkins University · completed · Relapsing Remitting Multiple Sclerosis
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.